glutathione and breast cancer risk

glutathione and breast cancer risk Targeting the redox-programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Oncology Letters

Name: glutathione and breast cancer risk Targeting the redox-programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Oncology Letters
Brand: vipetec.fi
SKU: 32294845466
Price: 25.66 USD
Availability: InStock
Rating: 4.2655 (29 reviews)

SKU: 32294845466

4.3

USD25.66 USD53.66

Pay in 4 interest-free payments of $6.42 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

Alshoiby, M

Lopez-Cavestany M, Hahn SB, Hope JM, et al

This precision-based strategy enhances antimicrobial efficacy while reducing the risk of resistance, by ensuring that nanomaterials are meticulously engineered to dismantle biofilm architecture and neutralize embedded pathogens

Navitoclax (ABT-263), another inhibitor of the BCL-2 family members, has also been used in many different studies over the years for its ability to eliminate senescent cells by inducing apoptosis